Inflammatory myopathies

Adverse Pregnancy Outcomes in Adult Patients With Idiopathic Inflammatory Myopathy: A Systematic Review and Meta‐Analysis

Arthritis Care Res (Hoboken)Published Systematic review and meta-analysis of retrospective cohort studies

Authors' conclusion

Our meta-analysis showed IIM to be associated with increased risk of hypertensive disorders of pregnancy, cesarean section, preterm birth, and infants who are small for gestational age or had intrauterine growth restriction, although residual confounding by disease activity and treatment may contribute.

Study context

Population
Pregnant adult patients with IIM (predominantly DM or PM) and pregnant patients without IIM; databases searched to May 15, 20255 population-based retrospective cohorts
Comparison
Pregnant patients with IIM vs pregnant patients without IIM
Outcome
Adverse pregnancy outcomes
Methodological detailspopulation-based retrospective cohorts, random-effects model with inverse-variance weighting, Newcastle-Ottawa Scale quality assessment
  • Population-based retrospective cohorts
  • Random-effects model with inverse-variance weighting
  • Newcastle-Ottawa Scale quality assessment

Pooled result

As reported in the abstract

Adverse pregnancy outcomes, pooled OR
IIM vs Without IIMOdds ratio (95% CI)P value
Hypertensive disorders of pregnancy; I2 = 70%, Cochran's Q P = 0.01
2.73(1.76–4.23)
overall effect P < 0.00001
Cesarean section; I2 = 79%, Cochran's Q P = 0.002
2.03(1.37–3.00)
overall effect P = 0.004
Preterm birth; I2 = 60%, Cochran's Q P = 0.06
3.71(2.35–5.85)
overall effect P < 0.00001
Small for gestational age or intrauterine growth restriction; I2 = 43%, Cochran's Q P = 0.15
1.90(1.03–3.51)
overall effect P = 0.04

Original publication

Adverse Pregnancy Outcomes in Adult Patients With Idiopathic Inflammatory Myopathy: A Systematic Review and Meta‐Analysis. Arthritis Care Res (Hoboken). Published 21 April 2026. doi:10.1002/acr.80048

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.